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Abstract
BACKGROUND: Dengue is a disease caused by four distinct serotypes of dengue virus (DENV 1-4). DENV serotype 
differs from one another by 25–40% at the amino acid level. The detection of serotype is very important due to the 
fact that in secondary infection with heterologous serotype often leads to life threatening, dengue hemorrhagic fever 
(DHF)/dengue shock syndrome (DSS); likewise, an infection caused by two serotypes or more in one individual can 
contribute to the severity of infection.
AIMS: The aims of the study were to detect the multiple dengue serotypes infection by quantitative reverse 
transcription polymerase chain reaction (Q-RT-PCR) and to determine the viral load in dengue infection.
MATERIALS AND METHODS: This study applied the molecular examination for determining the serotype and viral 
load of DENV. The data were analyzed using Student’s t-test.
RESULTS: A total of 119 samples, 91 samples showed positive dengue infection after amplification. The multiple 
dengue infection was found in 47 samples and 44 samples with single infection. There was a significant difference 
between the number of viral load DENV-2 and DENV-1 infection (p = 0.000). 
CONCLUSION: Two or more serotypes of dengue were found to infect a patient in West Sumatra. DENV-2 serotype 
was found predominantly in West Sumatra (n = 36, 39.56%) in patients with single infection. The molecular detection 
of dengue RNA by RT-PCR is a sensitive, rapid, and simple method. The RT-PCR method can detect the multiple 
dengue infection in clinical samples.
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Introduction
Dengue is a disease caused by four distinct 
serotypes of dengue virus (DENV 1-4). Dengue virus 
is an ss-RNA virus, spherical particles with diameter 
of 50 nm, belongs to the genus Flavivirus. The RNA 
genome of the virus is approximately 10.7 kb in length 
and encodes three structural (C, prM/M, and E) and 
seven non-structural (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B, and NS5) proteins. They are antigenically 
diverse and only share about 60–75% identity at the 
amino acid level [1], [2], [3], [4].
Dengue virus is a mosquito-transmitted virus 
that infects millions humans each year [5]. This virus 
is transmitted to humans through the bites of infected 
Aedes mosquitoes primarily by Aedes aegypti and 
Aedes albopictus mosquitoes [6], [7]. Infected human is 
the main carrier and spreader of DENV, the virus then 
is transmitted to uninfected mosquitoes for subsequent 
transmission. Dengue fever is one of the major 
human infectious diseases in tropical and subtropical 
areas [8], [9], [10].
Indonesia is one of the largest countries in the 
region of endemic dengue. Indonesia has experienced 
epidemic cycles of dengue since the first introduction 
in 1968. The frequent dengue cases are often followed 
by increasing number of infection which affected 
almost all provinces in Indonesia. Every year occurs 
the outbreak of dengue in several provinces with case 
fatality rate around 0.86–0.89%. Concurrent infection 
of multiple dengue serotypes has been reported in 
Indonesia, Mexico, and Puerto Rico as well as other 
countries [10], [11], [12], [13]. In 2010, Indonesia became 
the first ranked country in the Association of Southeast 
Asian Nations by the highest number cases of dengue 
hemorrhagic fever (DHF) and was predicated as a 
hyperendemic area because multiple serotypes were 
found in blood circulation of dengue patients [11], [14].
In dengue infection, detection of serotype 
is very important because the fact that in secondary 
infection with heterologous serotype often leads to 
life threatening, DHF and DSS [14]. Infection with one 
serotype does not confer cross-protection against the 
other serotypes, instead can cause a severe form 
of infection. Infection by one serotype provides the 
recovered patient with a lifelong immunity against 
specific serotype [15], [16]. Likewise, an infection 
caused by two serotypes or more in a single individual 
can contribute to the severity of infection, then 
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serotyping becomes very important in the management 
of patients with dengue virus infection [11].
At present, the previous methods that are 
used to diagnose DENV infection are virus isolation, 
detection of dengue specific antibodies and antigens, 
and amplification of viral RNA. To date, the molecular 
detection of dengue RNA by RT-PCR offers a sensitive, 
rapid, and simple. Several real-time PCR-based 
methods for the detection of DENV have been reported, 
these assays have targeted the 3’ UTR, NS5, capsid, 
and the envelope gene sequences. The increased 
prevalence of dengue infection in recent decades and 
high mortality caused by DHF and DSS need for more 
sensitive and specific diagnostic assays such as RT-PCR 
for the detection and typing of DENV [4], [8], [16].
During the acute phase of primary infection, 
RNA can usually be detected using various platforms 
PCR. Although PCR is more sensitive during secondary 
infection, the window of viremia is very short. The level 
of DENV viremia in early infection might be predictive 
for the development of severe disease later. It has been 
suggested that a viral titer 106–108 infectious units/mL 
during the febrile phase is predictive for the development 
of severe disease [3]. The high dengue viremia titer 
was associated with the increasing of disease severity. 
Peak viral titers were 100–1000-fold higher in patients 
with DSS than those with DHF in dengue infection. 
Although cases of DHF/DSS have been reported in 
individual without prior exposure to DENV, most of 
cases occurred in patients who have been sequentially 
infected by at least two DENV serotypes [17], [18]. The 
aims of this study were to detect of multiple dengue 
serotype infection by qRT-PCR and to determine the 
viral load in dengue infection patients.
Materials and Methods
Location and population of study
A total of 119 samples were used in this study, 
samples were collected from five clinical laboratories 
at public hospitals in West Sumatera (Dr. M. Djamil 
General Hospital, Padang; Dr. Ahmad Muchtar Regional 
Public Hospital, Bukit Tinggi; Regional Public Hospital, 
Padang Panjang, Regional Public Hospital, Pariaman, 
and Regional Public Hospital, Painan). This study was 
conducted on January 2018 to October 2019. This 
study used purposive sampling technique to investigate 
the multiple dengue infection in all subjects. All samples 
were collected within the first 5 days of illness. Samples 
were previously screened using NS1 and/or IgM 
and IgG anti-dengue detection. Molecular analysis 
was conducted in Biomedical Laboratory, Faculty of 
Medicine, Andalas University, Padang.
Preparation of samples
Blood samples were collected from each patient 
who visited clinical laboratory to conduct serologic 
dengue test and whole blood examination (hematology 
analyzer). Blood was taken using an aseptic procedure 
from the mediana cubiti vein by trained personnel, 
using 3 cc syringe. Serum was separated and stored at 
−80°C. All subjects were briefed on the study including 
the objectives, risks, and benefits of the study and 
inform consent was conducted through viva voce. The 
study was approved by Ethics Committee of Medical 
Faculty, Andalas University, Padang, Indonesia, No: 
268/KEP/FK/2019.
Viral RNA extraction and cDNA synthesis
Serum of patient’s with dengue fever was 
collected from blood and followed by RNA viral 
extraction. RNA viral was extracted from 140 uL serum 
samples using QIAamp Viral RNA Mini Kits (Qiagen, 
Germany) according to the manufacturer’s instructions 
and then stored at −80°C until further analysis.
The extracted RNA template was denatured at 
65°C for 10 min with DNAse Amp Grade (Invitrogen, 
USA) and then conversely transcribed to cDNA in 20 
uL reaction mixture comprising 11 uL RNA, 4 uL 5× 
trans Amp buffer, 1 uL reverse transcriptase, and 4 
uLDNAse/RNAse free water (Bioline cat no. Bio 65053). 
The reaction was allowed to proceed at 25°C for 5 min, 
46°C for 20 min, and followed by enzyme inactivation at 
95°C for 1 min.
Detection of DENV RNA by qRT-PCR
The RT-PCR was performed using nested 
qPCR method, the capsid gene was amplified by PCR 
with first round of PCR used outer primer Dengue_F 
(5’ to 3’): GAGAAACCGCGTGTCAAC and Dengue 
R: TCCTGCTTGCTGACTATCATG; furthermore, the 
second round of PCR used four specific primers DENV-1 
(5’ to 3’): TTCTTTCTTGAAACTCCGTAGC, DENV-2 
(5’ to 3’): GCGGGATTGTTAGGAAACGA, DENV-3 (5’ 
to 3’): CTTTTTCCGTCTGTTGATAATGC, and DENV-4 
(5’ to 3’): GACCTATCTCCTTCCTGAATCCAA. The 
primers were derived from positive screening of DENV. 
The DENV was amplified and sequenced to obtain the 
whole sequences. Then, Basic Local Alignment Search 
Tool was needed to confirm the result of isolation. The 
primer was designed by Primer3 (version 0.4.0). The 
size of the nested PCR product was 205 bp for DENV-
1, 125 bp for DENV-2, 244 bp for DENV-3, and 212 
bp for DENV-4. DNA amplification was performed with 
reaction conditions as follows: Denaturation at 95°C 
for 30 s and five cycles of denaturation at 95°C for 5 
s and annealing at 65°C for 5 s, and then 11 cycles 
touchdown (−1 C/cycle) denaturation at 95°C 5 s and 
annealing at 65°C to 55°C for 5 s. Furthermore, 19 
 Ismael et al. Detection of Multiple Dengue Infections by Rt-qPCR
Open Access Maced J Med Sci. 2020 May 05; 8(A):311-316. 313
cycles of denaturation at 95°C for 5 s, annealing at 
55°C for 5 s, and the melt curved at 65°–95° for 5 s 
(every 5 s the temperatures raised 0.5°C (Figure 1). 
For first round of PCR, 1 uL of cDNA added to 5 uL 
EvaGreen (Biorad, USA), 0.5 uL primer Dengue-F, 0.5 
uL primer Dengue-R, and 3 uL of nuclease-free water 
in 10 uL reaction mixture. External PCR was followed 
by the second round of nested PCR using the primer 
Dengue-F and four serotype-specific primers (DEN-1, 
DENV-2, DENV-3, and DENV-4). The amplified product 
of the external PCR was diluted in ratio of 1:100. The 
10 uL of nested PCR mixture was prepared by adding 
1 uL of diluted external PCR product to 5 uL EvaGreen 
(Biorad, USA), 0.5 uL of primer Dengue-F, 0.5 uL of 
each primers DENV-1 or DENV-2, or DENV-3, or DENV-
4, and 3 uL of nuclease-free water.
Viral load of dengue infection in West 
Sumatra
The viral load count showed that DENV-2 
(8.01 ± 0.79) log/mL was the highest serotype number 
than DENV-4 and DENV-1 (7.89 ± 1.01 and 7.57 ± 
0.61, respectively). Data of viral load for DENV-3 were 
not analyzed because only two samples were positive 
result. The number of viral load for DENV-2 and DENV-1 
showed significant difference (p < 0.05), while DENV-4 
was not significantly different. Based on gender, this 
study showed that most infected patients were male 
of 54 samples (59.34 %) and female of 37 samples 
(40.66%) (Table 2).
Figure 1.The profile of touchdown q-PCR
Statistical analysis
Statistical analysis was performed using SPSS 
15.0. Pooled data were presented as the average 
value. Data were compared using Student’s t-test, p < 
0.05 was considered statistically significant.
Results
The serotype of dengue infection in West 
Sumatra
In this study, 119 samples were obtained 
from serologic reactive patients, 91 samples 
(76.47%) showed positive dengue infection after 
PCR amplification, and 28 samples (23.36%) were 
negative. Positive results consist of multiple dengue 
infection 47 samples of 91 positive samples (51.64%) 
and 44 samples with single serotype dengue infection 
(48.33%). From 47 samples with multiple serotype 
dengue infection, 30 samples (32.97%) were infected 
by DENV-1 and DENV-2, 13 samples (14.28%) were 
infected by DENV-1, DENV-2, and DENV-4, three 
samples (3.30%) were infected by DENV-2 and DENV-
4, and one sample was (1.09%) infected by DENV-2 
and DENV-3. The sample with single serotype of 
dengue virus infection was five samples with DENV-1 
(5.49%), 36 samples with DENV-2 (39.56%), one 
sample with DENV-3 (1.09%), and two samples with 
DENV-4 (2.19%) (Table 1).
Table 1: Frequency of dengue serotype
Serotype Number of samples Percentage (%)
Multiple DENV:
DENV-1 and DENV-2 30 32.97
DENV-1, DENV-2, and DENV-4 13 14.28
DENV-2 and DENV-4 3 3.30
DENV-2 and DENV-3 1 1.09
Total 47 51.64
Single DENV:
DENV-1 5 5.49
DENV-2 36 39.56
DENV-3 1 1.09
DENV-4 2 2.19
Total 44 48.33
Table 2: The average of several parameters on dengue patients
Parameter n (%) Mean (SD) Min. Max. p-value
Gender
Male 54 (59.34)
Female 37 (40.66)
Hematology parameters
Platelet (/uL) 61,000 ± 30,490 15,000 132,000
Hematocrit (%) 39.62 ± 5.76 21 49
Leukocyte (/uL) 4364.71 ± 1483.05 2400 8400
Viral load (log mL-1)
DENV-2 8.01 ± 0.79 6.93 11.59 .000
DENV-1 7.57 ± 0.61 7.00 11.00 .138
DENV-4 7.89 ± 1.01 7.14 11.15
The results showed that hematology parameter 
such as thrombocyte was to decrease with the average 
61,000 per uL ± 30,490. Eleven samples (12.1%) with 
the number of thrombocyte were above 100.000/uL 
but <150.000/uL. The average of leukocyte count also 
decreased 4364.71/uL ± 1483, and hematocrit average 
was 39.62% ± 5.76 (hematocrit count was less than 
normal which found in 12 samples) (13.2%).
The curves of melt peak in Figure 2 showed 
specific result for DENV1, DENV2, DENV3, and DENV4. 
All serotypes showed one peak result with uniform melt 
peak temperature. The optimation temperature of the 
fourth serotypes for annealing was at 55°C and the melt 
curved at 65°–95°C.
Discussion
The dengue infection in West Sumatra was 
high, 91 samples (76.47%) showed positive result of 
119 samples. The serotype of dengue infection showed 
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that DENV-2 was found predominantly in West Sumatra 
(n = 36, 39.56%) in patients with single infection. 
Whereas, DENV1 and DENV2 dominated in multiple 
infection. In parameter of gender, it was found that male 
was slightly more affected by dengue virus than female.
In Indonesia, DENV-2 serotype dominated, 
followed by DEN-3 in 2003–2005. In 2008–2009, 
Surabaya was also dominated by DENV-2. Most of 
isolated DENV in Semarang was DENV-1, while the 
most predominant serotype in Purwokerto was DENV-3 
and other cities such as Jakarta, Palembang, and Bali 
in 2015, whereas DENV-4 was found in Bandung. 
These findings described that the differences of 
DENV serotype were found in different cities. Thus, it 
demonstrated the spatial and temporal dynamics of 
DENV distribution in Indonesia [11], [12].
Over the past few decades, the number of 
people infected with DENV has risen steadily due to 
the expansion of urban population, global travel and 
commerce, and paucity of mosquito control program [5].
There are many complex factors that may have 
contributed to the increase in dengue cases such as 
the increasing number of people migration, population 
growth, poverty, health inequality, and climate warming 
which have increased mosquito density and expanded 
the geographic distribution and seasonal distribution 
of Aedes mosquitoes [1]. Hot and wet environmental 
conditions increase the number of vector mosquito. 
Controlling of main vector is essential to prevent 
epidemics caused by the virus.
The number of multiple dengue case found 
has increased. In 2010, Indonesia became the first 
ranked country in with the highest number cases 
of DHF and hyperendemic predicate [11]. Dengue 
hyperendemic regions refer to locations with two or more 
simultaneously circulating dengue serotypes [19]. In 
many dengue hyperendemic countries, multiple DENV 
of all four serotypes are cocirculate [20]. Detection 
of dengue virus serotypes is very important because 
secondary infection with a different serotype may impact 
more severe. Likewise, an infection caused by two 
serotypes or more in a single individual can contribute 
to the severity of the infection. Then, serotyping is very 
important in the management of patients with dengue 
virus infection [11].
The dramatic increase in global dengue burden 
has promoted social interest in improving dengue 
diagnosis. The current methods for confirming dengue 
in the laboratory are serology test, viral isolation, and 
nucleotide detection [21]. Early diagnosis is important 
for the clinical management of dengue and may prevent 
unsatisfactory outcomes. Dengue virus and dengue 
viral products are detected in serum at the early 
illness period; consequently, the sensitivity of dengue 
diagnostic methods as real-time PCR, virus isolation, 
or NS1 detection is higher at the 1st day of illness [22].
Infection by one serotype provides the 
recovered patient with a lifelong immunity against the 
specific serotype. The previous studies have showed 
that if a recovered patient is infected with another 
serotype, the preexisting heterologous antibodies from 
previous infection complicate with novel serotype of 
dengue virus, but the pathogenesis not neutralized by 
the immune system. Instead, the complex of antigen 
antibody seems to facilitate the virus entry to the cells, 
which can cause an uncontrolled virus replication, higher 
peak viral titers, and more severe dengue disease [19].
The infection begins with an infected mosquito 
injects dengue virus, disseminates and infects multiple 
lymphoid and non-lymphoid tissues. A viremia is 
presumably representing the underlying severity of 
tissue infection. Viremia peaks shortly after fever onset 
and then becomes flat for 1–2 days before gradually 
declining [23]. Melt curve analyses is often used to 
confirm the fidelity of the reaction. Viremia was found 
to be higher in the initial days of illness decreasing 
gradually during the later stages of the infection [16]. 
Circulation of DENV remains detectable in blood during 
febrile period and is rapidly cleared with appearance 
of specific antibody [18]. In routine assay, two steps 
method with a RT-PCR followed by a nested PCR is 
used for serotyping of dengue viruses [14].
In this study, high multiple infection was 
detected in West Sumatra (51.64%) because every 
sample was amplified for 5 times, amplified with 
outer primer and with specific serotype (DENV1, 
DENV2, DENV3, and DENV4). Technically, this 
procedure could prevent mismatch between primer 
and target, as it occurs in PCR multiplex. Peripheral 
blood parameters change during the course of illness. 
Dengue fever is characterized by leukopenia <5000/uL, 
rising hematocrit up to 5–10%, and thrombocytopenia 
<150.000/uL. In dengue hemorrhagic fever, peripheral 
blood parameters characterized by thrombocytopenia 
<100.000/uL and hematocrit rise >20%. Thrombocyte 
contributes to increase vascular permeability by 
inflammation, depends on releasing of IL-1Ɓ. A rapid 
decrease in thrombocyte count, concomitant with a 
rising of hematocrit, leads the progression of plasma 
leakage[24]. As thrombocytopenia implicates higher 
Figure 2: Melting curves of DENV-1 to DENV-4 real-time RT-PCR 
products from patients who infected by dengue virus
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risk for menorrhagia [25]. Thrombocytopenia occurs 
commonly in laboratory-confirmed dengue cases on 
days 2–7. A patient with dengue had more severe 
thrombocytopenia on days 4–7, and the platelet 
count reached the lowest number on day 5 [26]. The 
pathogenesis of thrombocytopenia and leukopenia 
is suggested that dengue virus induced bone marrow 
suppression and depressed platelet and leukocyte 
synthesis and resulted in thrombocytopenia and 
leukopenia [7], [17].
Conclusion
Two or more serotypes of dengue were found 
to infect a patient in West Sumatra. DENV-2 serotype 
was found predominantly in West Sumatra (n = 36, 
39.56%) in patients with single infection. The molecular 
detection of dengue RNA by RT-PCR is a sensitive, 
rapid, and simple method. The RT-PCR method can 
detect the multiple dengue infection in clinical samples. 
The level of DENV viremia in early infection might be 
predictive for the development of severe disease later 
that can be beneficial for the management of patients 
with dengue virus infection.
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